Home / Consulting
Accelerate. Optimise. Consult.
Patients with a life-threatening diagnosis want access to the best treatments, as quickly as possible. Access Oncology is a consultancy business focused on accelerating your life-sciences launch in Australia & New Zealand — from market analysis through to successful launch.
We manage your product through the entire life cycle — market analysis, clinical trial development, registration and reimbursement, through to commercial launch.
A unique and committed team with depth of experience, an extensive network and a track record in launching rare-disease products through to blockbusters, with or without associated diagnostics.
Six core capability areas, deployed independently or as a full launch program — sized to the asset, the indication and the patient population.
Landscape mapping, segmentation, competitor analysis and pricing benchmarks across the ANZ region.
Trial design input, site selection, and clinical operations strategy aligned to TGA and Medsafe expectations.
TGA and Medsafe submissions, post-market obligations, label optimisation and risk management.
PBAC and MSAC submissions in Australia, Pharmac in New Zealand — including economic modelling and stakeholder engagement.
Companion-diagnostic strategy and partnership negotiation for precision-medicine therapies.
Launch readiness, sales-force design, commercial execution and patient access programs.
Whether you're entering ANZ for the first time or refreshing an existing portfolio strategy, Access Oncology can act as your in-country partner — embedded with your global team and accountable for execution.